ask="N/A"
ask_size="N/A"
average_daily_volume="2070800"
bid="N/A"
bid_size="N/A"
book_value="0.0730"
change="+0.0089"
change_from_200_day_moving_average="0.0339"
change_from_50_day_moving_average="0.0412"
change_from_52_week_high="-0.1606"
change_From_52_week_low="0.1024"
change_in_percent="+4.0363%"
close="0.2294"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0570"
ebitda="-16.83M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1000"
ex_dividend_date="N/A"
float_shares="230131000"
high="0.2300"
high_52_weeks="0.3900"
last_trade_date="2/22/2017"
last_trade_price="0.2294"
last_trade_size="2000"
last_trade_time="4:02pm"
low="0.2050"
low_52_weeks="0.1270"
market_capitalization="54.45M"
moving_average_200_day="0.1955"
moving_average_50_day="0.1882"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.5000"
open="0.2200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+17.3119%"
percent_change_from_50_day_moving_average="+21.8689%"
percent_change_from_52_week_high="-41.1795%"
percent_change_from_52_week_low="+80.6299%"
previous_close="0.2205"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.0205"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.8700"
stock_exchange="ASE"
symbol="RNN"
volume="2095654"
weeks_range_52="0.1270 - 0.3900"
